The 2022 DTRA Annual Meeting (November 6-9) convened the leaders advancing the global adoption of decentralized research. Sessions focused on progress to stabilize decentralized research, including perspectives from global regulators as well as updates on scaling adoption within multiple leading biopharmaceutical companies.

We look forward to bringing our Membership together again November 6-9, 2023 at the Encore Boston.


2022 Highlights  

The DTRA Regulatory update session featuring perspectives from:

  • Dr. Leonard Sacks - Office of Medical Policy, CDER, U.S. Food and Drug Administration
  • Dr. Catherine Ela - Head of the Clinical Trials Department, Israel Ministry of Health
  • Ditte Zerland Christensen - EU Project Manager, Danish Medicines Agency

Perspectives spanned expectations of guidance and harmonization, feedback on implementations to-date, and where regulators need more input from the DCT community.

 


Pharma Spotlights  

Our Pharma Spotlight Presentations featured DTRA Members sharing their DCT Journeys. Erica Lawson from Otsuka joined us to share about their first fully virtual trial and the lessons learned along the way. 

 

Registrants of the 2022 DTRA  Annual Meeting will be able to review recorded sessions in the Meeting App once they are posted.


Stay Informed on the Latest DTRA News

Join our mailing list to receive updates on the latest DTRA news, events, and more.  Subscribe Now